Cold Spring Harbor Laboratory announces exclusive license with plant breeding start-up Inari 4/16/2019 CSHL announced a licensing agreement with partner Inari, a company that is advancing plant breeding by tapping nature’s genetic diversity. Read the story »
Breakthrough Prize laureates meet at CSHL 12/6/2018 Breakthrough Prize winner Adrian Krainer & C. Frank Bennett reunite for the first time since their award ceremony at CSHL to discuss further project. Read the story »
The case for open and inclusive science 6/8/2018 America must continue to a place where the most talented people in the world want to live, study and work. Read the story »
Andrew Whiteley appointed VP of Business Development and Technology Transfer at CSHL 4/3/2018 Life science business leader Andrew Whiteley becomes the Vice President of CSHL's Business Development and Technology Transfer department. Read the story »
Library of CRISPR targeting sequences increases power and accuracy of the gene-editing method 7/20/2017 New library of RNA sequences that can be used by researchers to direct the CRISPR-cas9 complex to cut DNA with unprecedented precision. Read the story »
Executive in Residence to mentor scientific entrepreneurs at Cold Spring Harbor Laboratory 4/15/2016 Andrew Whiteley joined the Cold Spring Harbor Laboratory Office of Technology Transfer as the first Executive in Residence. Read the story »
Cold Spring Harbor Laboratory engages Hairpin Technologies Inc. to license its short hairpin RNA (shRNA) technology 3/31/2015 Cold Spring Harbor Laboratory engaged Hairpin Technologies Inc. to expand the commercial distribution and research use of short hairpin RNA. Read the story »
Cold Spring Harbor Laboratory and GSK to develop diabetes and obesity therapeutic 3/23/2015 CSHL announced a collaboration with GSK to develop a treatment for obesity and type 2 diabetes. Read the story »
Mechanistic insights into spinal muscular atrophy suggest new paths for treatment 1/12/2015 Researchers find that in mouse models of the disease subcutaneous drug administration is sufficient to treat SMA Read the story »
Cold Spring Harbor Laboratory announces settlement in patent malpractice case against Ropes & Gray 6/2/2014 CSHL ramps up licensing of its short-hairpin RNA technology already used widely in cancer research and drug development Read the story »
Ohr Pharmaceutical and CSHL announce joint venture to develop trodusquemine and related analogs 3/3/2014 Ohr Pharmaceutical and CSHL announce a new joint venture to develop trodusquemine and related analogs. Read the story »
Cold Spring Harbor Laboratory appoints Teri F. Willey to accelerate commercialization efforts 9/6/2013 As VP of Business Development & Technology Transfer, Willey will build on strong record of success in venture capital and research commercialization Read the story »
RNA Interference Library covers entire human genome 3/24/2004 CSHL scientists created the first library of human RNA interference clones. Read the story »
